Erythropoiesis-stimulating agents-benefits and harms in the treatment of anemia in cancer patients.

brigittemeiswinkel 19. Februar 202426. Februar 2024

Heregger, R; Greil, R.

memo 16, 259–262 (2023). https://doi.org/10.1007/s12254-023-00902-4.

https://link.springer.com/article/10.1007/s12254-023-00902-4